August 10, 2022 Allergy/Immunology A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
August 9, 2022 Allergy/Immunology Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease
August 4, 2022 Bioengineering Study succeeds at restoring selected molecular and cellular processes across multiple vital organs after death in pigs. Far from human use and a plethora of bioethical questions remain to be addressed.
July 5, 2022 Clinical Research Amid buzz around the medical benefits of psilocybin, a new production facility gets to work in B.C. Studies are ongoing with early evidence pointing to its ability to relieve symptoms in adults suffering from treatment-resistant depression.
June 24, 2022 Clinical Research End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.
June 15, 2022 Bioengineering Study in Nature outlines how in vitro and in vivo (mouse model), specific white blood cells (B-Cells) can be genetically programmed to produce anti-HIV antibodies thus offer a one-time treatment for the disease. Long way to go but elegant study design.
May 25, 2022 Clinical Research Pfizer applies to FDA for approval of three-dose pediatric COVID-19 vaccine for children under five years of age.
May 13, 2022 Clinical Research Interesting study posits that NSAIDs used to treat low back pain interferes with the healing process and thus may lead to chronic pain conditions thereafter.
May 12, 2022 Clinical Research Study finds a way forward for potential new treatments as gene that causes Lupus has been discovered.
